Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at AACR Annual Meeting 2024

2024-03-11
|
Page View:

1.png

Join Medicilon at the AACR Annual Meeting 2024
The AACR Annual Meeting is a premier gathering for cancer researchers, where groundbreaking advances in cancer science and medicine are shared. Medicilon is thrilled to exhibit at this crucial event.


Medicilon: Your One-Stop R&D Partner
As a leading integrated CRO, Medicilon offers comprehensive drug discovery services for pharmaceutical and research institutions worldwide. By the end of 2023, we've served over 2,000 clients globally, with 300+ INDs approved in China and 80+ overseas.


Unparalleled Expertise in Immuno-Oncology
Medicilon boasts over 370 tumor evaluation models. We're at the forefront of immuno-oncology research, actively supporting the evaluation and development of innovative therapies like CAR-T, TCR-T, and more.


Date: April 5-10, 2024
Location: San Diego Convention Center, San Diego, California
Medicilon Booth #4021


Meet Dr. Qingcong Lin, President of Medicilon USA Corp. 
Dr. Lin brings nearly 40 years of experience in pharmaceutical R&D, making significant contributions to both academia and the global industry. Visit him at Medicilon booth #4021 to discuss your research needs.

4.png

Meet Dr. Wenjie Li, Vice President of the CMC Unit at Medicilon

With nearly three decades in pharmaceutical R&D management, Dr. Li has deep expertise in drug development, including CMC services and CRO/CDMO management, accumulating rich experience and profound knowledge.

Dr.Li.png

Meet with Medicilon
Subject丨AACR Annual Meeting 2024

Share:
Return
Relevant newsRelevant news